Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE, et al
The makers of TruTan let you stock up on your must-have shades so you can flaunt a glow when the moment strikes
Thirty years of nrf2: advances and therapeutic challenges
The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status
By the end of 2024, 60% of med spas offered GLP-1 programs
Consequently, the administration of probiotic supplements is being explored as a strategic bio-therapy to standardize and enhance the conversion of glucoraphanin to SFN, thereby ensuring a more reliable and sustained delivery of the bioactive compound from dietary sources (52)